AHA 2026 Schema for Acute Pulmonary Embolism

Assessment of Pulmonary Embolism (PE)

Pulmonary embolism (PE) is a potentially life-threatening condition requiring rapid, structured, and guideline-directed evaluation. Early risk stratification determines urgency of imaging, need for thrombolysis, and level of care.

This post summarizes a practical, ESC-aligned approach to assessment of PE.

---

1. Clinical Suspicion

Always think of PE in patients with:

• Acute unexplained dyspnea
• Pleuritic chest pain
• Hemoptysis
• Syncope
• Unexplained tachycardia
• New hypoxia

Risk Factors

• Recent surgery or immobilization
• Active cancer
• Previous VTE
• Pregnancy/postpartum
• OCP use
• Thrombophilia
• Obesity

---

2. Hemodynamic Assessment (First Step)

Immediately determine if the patient is:

A. Hemodynamically Unstable (High-Risk PE)

• SBP <90 mmHg
• Drop in SBP ≥40 mmHg
• Shock or cardiac arrest

→ Urgent bedside echocardiography → If RV dysfunction present → treat as high-risk PE (consider thrombolysis)

---

3. Clinical Probability Assessment

Use validated scoring systems.

Wells Score for PE

• Clinical signs of DVT – 3
• PE most likely diagnosis – 3
• HR >100 – 1.5
• Immobilization/surgery – 1.5
• Previous VTE – 1.5
• Hemoptysis – 1
• Cancer – 1

Interpretation:

• ≤4 → PE unlikely

• 4 → PE likely

---

Revised Geneva Score

Objective alternative without subjective component.

---

4. D-Dimer Testing

• Use only in low or intermediate probability
• Age-adjusted cutoff:
  Age × 10 (if age >50)

If negative → PE excluded
If positive → proceed to imaging

---

5. Imaging Modalities

CT Pulmonary Angiography (CTPA) – Gold Standard

• Direct visualization of intraluminal filling defect
• Assesses clot burden
• Evaluates RV size

---

Ventilation–Perfusion (V/Q) Scan

• Useful in renal failure
• Pregnancy
• Contrast allergy

---

Compression Ultrasound

• If proximal DVT present → treat as PE (if imaging unavailable)

---

6. ECG in PE

Common findings:

• Sinus tachycardia (most common)
• S1Q3T3 pattern
• T-wave inversion V1–V4
• RBBB

ECG is neither sensitive nor specific but helps risk stratification.

---

7. Echocardiography

Key findings:

• RV dilation (RV/LV >1)
• McConnell sign
• D-shaped LV
• Elevated pulmonary pressures

Echo is essential in unstable patients.

---

8. Biomarkers

• Troponin → RV myocardial injury
• BNP / NT-proBNP → RV strain

Positive biomarkers indicate worse prognosis.

---

9. Risk Stratification After Diagnosis

Using PESI / sPESI

• Low risk → outpatient consideration
• High risk → inpatient monitoring

ESC Risk Categories

Category	Hemodynamics	RV Dysfunction	Troponin
High Risk	Shock	±	±
Intermediate-High	Stable	+	+
Intermediate-Low	Stable	+	–
Low Risk	Stable	–	–

---

10. Stepwise Algorithm

1. Assess hemodynamic status
2. If unstable → bedside echo → urgent reperfusion
3. If stable → assess clinical probability
4. Low probability → D-dimer
5. Positive D-dimer → CTPA
6. After diagnosis → risk stratify (PESI + RV + biomarkers)

---

Key Clinical Pearls

• Do not delay anticoagulation in high suspicion unless contraindicated
• Age-adjusted D-dimer reduces unnecessary CT scans
• Echo is a prognostic tool, not a rule-out test
• Always reassess for chronic thromboembolic pulmonary hypertension (CTEPH) if symptoms persist

---

Conclusion

Assessment of PE requires rapid clinical judgment combined with structured scoring systems, laboratory testing, and imaging. Early risk stratification determines prognosis and guides management decisions including thrombolysis and level of care.